• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran.伊朗呼罗珊拉扎维省伊朗地中海贫血患者中凯尔和Rh同种抗体的频率
Int J Hematol Oncol Stem Cell Res. 2023 Jan 1;17(1):4-8. doi: 10.18502/ijhoscr.v17i1.11707.
2
Frequency and specificity of red cell antibodies in thalassemia patients in Albania.阿尔巴尼亚地中海贫血患者红细胞抗体的频率和特异性
Int J Lab Hematol. 2015 Aug;37(4):569-74. doi: 10.1111/ijlh.12362. Epub 2015 Apr 11.
3
Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.地中海贫血患者的输血与同种免疫:多中心研究
Pediatr Hematol Oncol. 2011 Sep;28(6):479-85. doi: 10.3109/08880018.2011.568595.
4
Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.巴基斯坦定期输血的β地中海贫血患者中的红细胞同种免疫
Transfus Med. 2015 Apr;25(2):106-10. doi: 10.1111/tme.12196. Epub 2015 Apr 14.
5
Study of alloimmunization and autoimmunization in Iranian β-thalassemia major patients.伊朗重型β地中海贫血患者的同种免疫和自身免疫研究。
Asian J Transfus Sci. 2016 Jan-Jun;10(1):88-92. doi: 10.4103/0973-6247.172179.
6
Red cell alloantibodies in beta-thalassaemia major patients' blood referring to the regional blood transfusion center of Tehran, Iran.伊朗德黑兰地区输血中心的重型β地中海贫血患者血液中的红细胞同种抗体
Bioimpacts. 2021;11(2):129-133. doi: 10.34172/bi.2021.20. Epub 2020 Apr 20.
7
Optimal blood grouping and antibody screening for safe transfusion.安全输血的最佳血型鉴定与抗体筛查。
Prilozi. 2009 Jul;30(1):119-28.
8
RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.伊朗南部输血依赖型β地中海贫血患者的红细胞同种免疫
Int J Lab Hematol. 2007 Oct;29(5):321-6. doi: 10.1111/j.1365-2257.2006.00856.x.
9
Alloimmunization in Thalassemia Patients: New Insight for Healthcare.地中海贫血患者的同种免疫:医疗保健的新见解。
Int J Prev Med. 2017 Dec 5;8:101. doi: 10.4103/ijpvm.IJPVM_246_16. eCollection 2017.
10
RBC alloimmunization and double alloantibodies in thalassemic patients.地中海贫血患者的红细胞同种免疫和双重同种抗体
Hematology. 2015 May;20(4):223-7. doi: 10.1179/1607845414Y.0000000189. Epub 2014 Aug 17.

引用本文的文献

1
Investigation of alloimmunization in beta-thalassemia major patients: a cross-sectional study.重型β地中海贫血患者同种免疫的调查:一项横断面研究。
Ann Med Surg (Lond). 2025 Mar 19;87(4):1893-1896. doi: 10.1097/MS9.0000000000003092. eCollection 2025 Apr.
2
Prevalence of Alloimmunization Events in Thalassemia Patients With Repeated Transfusions in the Rhesus Blood Group System: A Systematic Review and Meta Analysis.恒河猴血型系统中反复输血的地中海贫血患者同种免疫事件的患病率:一项系统评价和荟萃分析
J Clin Med Res. 2025 Feb;17(2):106-118. doi: 10.14740/jocmr6142. Epub 2025 Jan 17.

本文引用的文献

1
Rh and Kell blood group antigen prevalence in a multi-ethnic cohort in Nigeria: implications for local transfusion service.尼日利亚多民族队列中Rh和Kell血型抗原的流行情况:对当地输血服务的影响
Immunohematology. 2018 Jun;34(2):61-65.
2
Risks of red blood cell alloimmunization in transfusion-dependent β-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review.阿曼依赖输血的β地中海贫血患者红细胞同种免疫的风险:一所大学三级医疗参考中心的25年经验及文献综述
Transfusion. 2018 Apr;58(4):871-878. doi: 10.1111/trf.14508. Epub 2018 Feb 4.
3
The Direct Antiglobulin Test: Indications, Interpretation, and Pitfalls.直接抗球蛋白试验:适应证、解读及陷阱
Arch Pathol Lab Med. 2017 Feb;141(2):305-310. doi: 10.5858/arpa.2015-0444-RS.
4
Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India.地中海贫血患者红细胞同种免疫和自身免疫的发生率:来自印度东部的报告。
Adv Hematol. 2015;2015:610931. doi: 10.1155/2015/610931. Epub 2015 Sep 6.
5
RBC alloimmunization and double alloantibodies in thalassemic patients.地中海贫血患者的红细胞同种免疫和双重同种抗体
Hematology. 2015 May;20(4):223-7. doi: 10.1179/1607845414Y.0000000189. Epub 2014 Aug 17.
6
Alloimmunization among transfusion-dependent thalassemia patients.输血依赖型地中海贫血患者的同种免疫
Asian J Transfus Sci. 2009 Jul;3(2):95-8. doi: 10.4103/0973-6247.53884.
7
Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin.印度裔多次输血地中海贫血患者中的同种免疫和红细胞自身免疫
Hematology. 2010 Jun;15(3):174-7. doi: 10.1179/102453309X12583347114013.
8
RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.伊朗南部输血依赖型β地中海贫血患者的红细胞同种免疫
Int J Lab Hematol. 2007 Oct;29(5):321-6. doi: 10.1111/j.1365-2257.2006.00856.x.
9
Reducing adverse events in blood transfusion.减少输血不良反应
Br J Haematol. 2005 Oct;131(1):8-12. doi: 10.1111/j.1365-2141.2005.05702.x.
10
Red cell immunization in beta thalassaemia major.重型β地中海贫血中的红细胞免疫
J Coll Physicians Surg Pak. 2004 Nov;14(11):657-60.

伊朗呼罗珊拉扎维省伊朗地中海贫血患者中凯尔和Rh同种抗体的频率

Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran.

作者信息

Mollahoseini Foomani Farzad, Sadeghian Mohammad Hadi, Bagheri Saeede, Badiee Zahra, Bazargani Reihane, Aryanpour Zahra, Hallajiayan Saeid, Shams Seyyede Fatemeh

机构信息

Blood Transfusion Organization Research Center, Iranian blood transfusion organization, Mashhad, Iran.

Cancer Molecular Pathology Research Center. Mashhad University of Medical Sciences. Mashhad, Iran.

出版信息

Int J Hematol Oncol Stem Cell Res. 2023 Jan 1;17(1):4-8. doi: 10.18502/ijhoscr.v17i1.11707.

DOI:10.18502/ijhoscr.v17i1.11707
PMID:37638288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10448921/
Abstract

Thalassemia is an inherited disease with anemia and hemolysis. Blood transfusion is a routine treatment for thalassemia patients; alloimmunization is one of the complications of blood transfusion, which is very serious for these patients, especially girls and young women. In this cross-sectional study, 446 thalassemia patients were examined. Demographic information of patients was extracted and recorded. The phenotype of ABO, Rh, and Kell antigens (tube method) with antisera from IMMUNDIANOSTICA Company (Germany) and the frequency of alloantibodies were determined. 55.8% of the studied individuals were male, and 44.2% were female. Mean age of the studied patients was 19.94±10.63. The alloantibodies were detected in 7.5% of cell-pack receivers. The most prevalent phenotype of the ABO system was the O blood group (37.4%), and the most abundant antigen of the Rh group was 'e', which was found in 99.8% of the studied population. The most common alloantibody detected was Anti K (38.2%); concerning kell phenotype, (Kk) and (Kk) were found in 99.3% and 0.7% of patients, respectively. The frequency of Anti-D, Anti-C, Anti-c, and Anti-E was 23.5%, 14.7%, 2.9%, and 14.7%, respectively. According to the results of this paper, finding the compatible packed cells in terms of Kell and Rh systems antigens in addition to the ABO blood group is recommended to decrease the rate of alloantibodies in thalassemia patients.

摘要

地中海贫血是一种伴有贫血和溶血的遗传性疾病。输血是地中海贫血患者的常规治疗方法;同种免疫是输血的并发症之一,对这些患者,尤其是女孩和年轻女性来说非常严重。在这项横断面研究中,对446例地中海贫血患者进行了检查。提取并记录了患者的人口统计学信息。使用德国IMMUNDIANOSTICA公司的抗血清,通过试管法测定ABO、Rh和Kell抗原的表型以及同种抗体的频率。研究对象中55.8%为男性,44.2%为女性。研究患者的平均年龄为19.94±10.63岁。在7.5%的红细胞输注接受者中检测到了同种抗体。ABO系统中最常见的表型是O血型(37.4%),Rh组中最常见的抗原是“e”,在99.8%的研究人群中发现。检测到的最常见同种抗体是抗K(38.2%);关于Kell表型,(Kk)和(Kk)分别在99.3%和0.7%的患者中发现。抗-D、抗-C、抗-c和抗-E的频率分别为23.5%、14.7%、2.9%和14.7%。根据本文结果,建议除ABO血型外,在Kell和Rh系统抗原方面找到相容的红细胞,以降低地中海贫血患者同种抗体的发生率。